Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Gait Pattern Analysis and Feasibility of Gait Training With a Walking Assist Robot in Stroke Patients and Elderly Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02843828
Recruitment Status : Completed
First Posted : July 26, 2016
Last Update Posted : April 10, 2019
Sponsor:
Collaborator:
Samsung Electronics
Information provided by (Responsible Party):
Yun-Hee Kim, Samsung Medical Center

Brief Summary:
The purpose of this study was to investigate the effects of the new wearable hip assist robot developed by Samsung Advanced Institute of Technology (Samsung Electronics Co, Ltd., Korea) to gait rehabilitation in elderly adults and stroke patients.

Condition or disease Intervention/treatment Phase
Stroke Healthy Device: gait rehabilitation with Samsung Hip Assist v1 Other: gait rehabilitation without Samsung Hip Assist v1 Not Applicable

Detailed Description:

Randomized, two treatment groups

Number of Subjects : 54 subjects (n=27 per group)

Group 1 : gait rehabilitation with hip assist robot / 10 sessions (5sessions - treadmill gait training / 5sessions - overground gait training), 30min per session

Group 2 : gait rehabilitation without hip assist robot / 10 sessions (5sessions - treadmill gait training / 5sessions - overground gait training), 30min per session

Primary objective is to demonstrate the effects of hip assist robot on spatio-temporal parameters measured by motion capture system (Motion Analysis Corporation, Santa Rosa, CA, USA), muscle activation patterns measured by surface electromyography (sEMG) (Noraxon Inc., Scottsdale, AZ, USA), metabolic energy cost parameters measured by portable cardiopulmonary metabolic system (Cosmed K4B2, Rome, Italy) and foot pressure distribution measured by F-Scan Mobile system (Tekscan Inc., South Boston, MA, USA).

Secondary objective is to demonstrate the effects of hip assist robot on motor function improvement evaluated by Berg Balance Scale (BBS), Tinetti performance oriented mobility assessment (POMA), Korean version Modified Bathel index (K-MBI), Modified Rankin Scale (MRS), Functional Ambulation Classification (FAC), Fugl-Meyer assessment for lower extremity (FMA), Korean version Fall Efficacy Scale (K-FES), Manual Muscle Test (MMT) and Range of Motion (ROM).

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 56 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Gait Pattern Analysis and Feasibility of Gait Training With a Newly Developed Walking Assist Robot in Stroke Patients and Elderly Adults
Actual Study Start Date : January 2, 2016
Actual Primary Completion Date : August 30, 2017
Actual Study Completion Date : September 1, 2017

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Rehabilitation

Arm Intervention/treatment
Experimental: Samsung Hip Assist v1
gait rehabilitation with Samsung Hip Assist v1 10 sessions (5sessions - treadmill gait training / 5sessions - overground gait training), 30 min per session
Device: gait rehabilitation with Samsung Hip Assist v1
Participants will participate in 10 sessions of gait rehabilitation with Samsung Hip Assist v1 (5sessions-treadmill gait training / 5sessions-overground gait training), 30min per session

Active Comparator: Conventional gait training
gait rehabilitation without Samsung Hip Assist v1 10 sessions (5sessions - treadmill gait training / 5sessions - overground gait training), 30 min per session
Other: gait rehabilitation without Samsung Hip Assist v1
Participants will participate in 10 sessions of gait rehabilitation without Samsung Hip Assist v1 (5sessions-treadmill gait training / 5sessions-overground gait training), 30min per session




Primary Outcome Measures :
  1. Change in 10 meter walk test from baseline in gait speed [ Time Frame: session 0 (initial visit); session 11 (at approximately 4 weeks) ]
    Measure of self selected speeds by measuring the time it takes an individual to walk 10 meters. To perform the test, patient walks 10 meters (33 ft) and the time is measured when the leading foot crosses the start line and the finish line. The instructions are: "Please walk this distance at your normal pace when I say go."


Secondary Outcome Measures :
  1. Berg Balance Scale (BBS) [ Time Frame: session 0 (initial visit); session 11 (at approximately 4 weeks) ]
    The BBS is a 14-item objective measure designed to assess static balance and fall risk in adult populations and is a well-accepted measure in the stroke literature. The functional activities that are assessed include sitting and standing balance during transfers, altered base of support, reaching, turning, eyes open and closed.

  2. Tinetti performance oriented mobility assessment (POMA) [ Time Frame: session 0 (initial visit); session 11 (at approximately 4 weeks) ]
    Task-oriented outcome measure that assesses gait and balance ability is composed of a 9-item gait portion (POMA-G) and 7-item balance portion (POMA-B).

  3. Modified Bathel index (MBI) [ Time Frame: session 0 (initial visit); session 11 (at approximately 4 weeks) ]
    The MBI is a measure of activities of daily living, which shows the degree of independence of a patient from any assistance. It covers 10 domains of functioning (activities): bowel control, bladder control, as well as help with grooming, toilet use, feeding, transfers, walking, dressing, climbing stairs, and bathing.

  4. Modified Rankin Scale (MRS) [ Time Frame: session 0 (initial visit); session 11 (at approximately 4 weeks) ]
    The modified Rankin Scale (mRS) is a commonly used scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability.

  5. Functional Ambulation Classification (FAC) [ Time Frame: session 0 (initial visit); session 11 (at approximately 4 weeks) ]
    The Functional Ambulation Categories (FAC) is a functional walking test that evaluates ambulation ability. This 6-point scale assesses ambulation status by determining how much human support the patient requires when walking, regardless of whether or not they use a personal assistive device.

  6. Fugl-Meyer assessment for lower extremity (FMA) [ Time Frame: session 0 (initial visit); session 11 (at approximately 4 weeks) ]
    The Fugl-Meyer Assessment (FMA) is a stroke-specific, performance-based impairment index. It is designed to assess motor functioning, balance, sensation and joint functioning in patients with post-stroke hemiplegia. It is applied clinically and in research to determine disease severity, describe motor recovery, and to plan and assess treatment.

  7. Fall Efficacy Scale (FES) [ Time Frame: session 0 (initial visit); session 11 (at approximately 4 weeks) ]
    Fall Efficacy Scale (FES) is a 10-item questionnaire designed confidence in their ability to perform 10 daily tasks without falling as an indicator of how one's fear of falling impacts physical performance. Each item is rated from 1 ("very confident") to 10 ("not confident at all"), and the per item ratings are added to generate a summary total score.

  8. Manual Muscle Test (MMT) [ Time Frame: session 0 (initial visit); session 11 (at approximately 4 weeks) ]
    Manual muscle testing (MMT) is a procedure for the evaluation of the function and strength of individual muscles and muscle groups based on the effective performance of a movement in relation to the forces of gravity and manual resistance.

  9. Range of Motion (ROM) [ Time Frame: session 0 (initial visit); session 11 (at approximately 4 weeks) ]
    Range of Motion (ROM) testing is the measurement of movement around a specific joint or body part.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   50 Years to 84 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Elderly adults

    1. Age: between 65 and 84 years
    2. elderly adults who had no neurological or musculoskeletal abnormalities affecting gait
    3. Ability to walk at least 10m regardless of assist devices
    4. High levels of physical performance (SPPB > 7)
    5. Subject is willing to be randomized to the control group or the treatment group
  • Stroke

    1. Age: between 50 and 84 years
    2. ≥ 3 months post stroke
    3. Ability to walk at least 10m regardless of assist devices
    4. Adequate gait function (FAC > 3)
    5. Physician approval for patient participation
    6. Subject is willing to be randomized to the control group or the treatment group

Exclusion Criteria:

  • Elderly adults

    1. History of any diseases (eg. lower extremity orthopedic diseases, neurologic disorders, cardiovascular disease, heart failure, uncontrolled hypertension that affect walking capacity, efficiency, and endurance)
    2. Severe visual impairment or dizziness that increases the risk of falls
  • Stroke

    1. Serious cardiac conditions (hospitalization for myocardial infarction or heart surgery within 3 months, history of congestive heart failure, documented serious and unstable cardiac arrhythmias, hypertrophic cardiomyopathy, severe aortic stenosis, angina or dyspnea at rest or during activities of daily living)
    2. Advanced liver, kidney, cardiac, or pulmonary disease
    3. History of concussion in last 6 months
    4. History of unexplained, recurring headaches, epilepsy/seizures/skull fractures or skull deficits
    5. Preexisting neurological disorders such as Parkinson's disease, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), dementia

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02843828


Locations
Layout table for location information
Korea, Republic of
Samsung Medical Center
Seoul, Korea, Republic of
Sponsors and Collaborators
Samsung Medical Center
Samsung Electronics
Investigators
Layout table for investigator information
Study Chair: Yun-Hee Kim, MD, PhD Samsung Medical Center
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Yun-Hee Kim, Professor, MD, PhD, Samsung Medical Center
ClinicalTrials.gov Identifier: NCT02843828    
Other Study ID Numbers: 2015-05-013-003
First Posted: July 26, 2016    Key Record Dates
Last Update Posted: April 10, 2019
Last Verified: April 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Yun-Hee Kim, Samsung Medical Center:
Exoskeleton Device
elderly
stroke
gait rehabilitation
Additional relevant MeSH terms:
Layout table for MeSH terms
Stroke
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases